United States - English - NLM (National Library of Medicine)

dompé farmaceutici s.p.a. - cenegermin (unii: b6e7k36kt8) (cenegermin - unii:b6e7k36kt8) - oxervate®  (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis. none. risk summary there are no data from the use of oxervate in pregnant women to inform any drug associated risks. administration of cenegermin-bkbj to pregnant rats or rabbits during the period of organogenesis did not produce adverse fetal effects at clinically relevant doses. in a pre- and postnatal development study, administration of cenegermin-bkbj to pregnant rats throughout gestation and lactation did not produce adverse effects in offspring at clinically relevant doses. data animal data in embryofetal development studies, daily subcutaneous administration of cenegermin-bkbj to pregnant rats and rabbits throughout the period of organogenesis produced a slight increase in post-implantation loss at doses greater than or equal to 42 mcg/kg/day (267 times the mrhod). a no observed adverse effect level (noael) was not established for post-implantation loss in either species. in rats

Canada - English - Health Canada

dompÉ farmaceutici s.p.a. - cenegermin - solution - 0.002% - cenegermin 0.002% - eent drugs, miscellaneous

Israel - English - Ministry of Health

mind pharma europe ltd. - cenegermin - eye drops, solution - cenegermin 20 mcg / 1 ml - cenegermin - treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

jace pharma pty ltd - cenegermin, quantity: 20 microgram/ml - eye drops, solution - excipient ingredients: trehalose dihydrate; macrogol 6000; hypromellose; monobasic sodium phosphate dihydrate; mannitol; methionine; dibasic sodium phosphate; water for injections - treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults.

European Union - English - EMA (European Medicines Agency)

dompe farmaceutici s.p.a. - recombinant human nerve growth factor - keratitis - ophthalmologicals - treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dompe uk ltd - cenegermin - eye drops - 20microgram/1ml

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios recalcine, s.a . - fentermina(clorhidrato) - fentermina(clorhidrato)....37.5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios saval, s.a. - fentermina clorhidrato - fentermina clorhidrato....37.50 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

productos medix s.a. de c.v. - fentermina(clorhidrato) - fentermina(clorhidrato)....30 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

productos medix, s.a de c.v - fentermina(clorhidrato) - fentermina(clorhidrato)....15.00 mg